Both LAR and LAR-B have broad-spectrum antibacterial activity. To study these antibiotic molecules more easily, the authors transferred all the genes required for LAR synthesis, modification ...

Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective at killing both gram-positive and gram-negative pathogenic bacteria, along ...

The study reveals lariocidin, a potent ribosome-targeting antibiotic, with unique mechanisms that could combat drug-resistant ...

A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives ...

Conclusion. Doripenem is an injectable carbapenem antibiotic with a spectrum of activity comparable to that of imipenem and meropenem. Its safety is similar to that of other carbapenems.

Research: A broad-spectrum lasso peptide antibiotic targeting the bacterial ... Its antimicrobial activity was even stronger in nutrient-limited media that mimic host environments, suggesting ...

Drug-resistant bacteria are one of the most urgent threats in modern medicine. But scientists are looking to oysters for help ...

Non-Ribosomal Peptide Antibiotics Dominated the Market with USD 1.4 Billion Valuation in 2024 Due to Enhanced EfficacyDublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Antibiotics Market ...